The Association of Biotechnology Led Enterprises (ABLE) will host the 11th edition of 2014 BIOINVEST on October 17, 2014 in Bangalore.
Dr Goutam Das, Chief Operating Officer, ABLE will give the introductory speech and the key note address will be given by Dr PM Murali, President, ABLE.
Panel discussions will be held on ‘The art of a biotechnology deal’, which will be moderated by Utkarsh Palnitkar, Partner, Head of Advisory, Head Life Sciences KPMG, where Dr Rashmi Barbhaiya, Chief Executive Officer and Managing Director, Advinus will share the insights on the Advinus-Takeda deal.
The panel discussion on ‘Investing in intellectual capital creation (education and training)’ will have Dr PM Murali, President, ABLE, Dr PK Khosla, Vice Chancellor, Shoolini University, Vijayanti Margassery, Associate Director Human Resources, Biocon as the panelists. The panel discussion on ‘Investment trends in mature biotech markets – Lessons for India’ will have Sanjay Singh, Director -Corporate Finance, KPMG, Dr Renu Swarup, Managing Director, BIRAC, Ravi Tyagi, General Manager, SIDBI; Former Head SME Project – NSE, Vikas Dawra, MD-Investment Banking, Yes Bank and Sunny Sharma, Senior Managing Director, Orbimed Advisors, as the panelists.
Swaminathan Dandapani, Executive Chairman, Manipal Hospitals, Dr Abhay Jere. Associate Vice President & Head – Persistent Labs| Persistent Systems, Dr Anu Acharya, Chief Executive Officer, mapmygenome, Ati Ranjan Kumar, AVP, Investment Research Aranca will take part in the panel discussion on ‘The ‘big data’ healthcare business revolution.’
EP News Bureau – Mumbai